Table I.
Baseline parameters of both groups.
| Parameter | Treated group (n=40) | Control group (n=43) | P-value |
|---|---|---|---|
| Age (years) | 32.50±3.56 | 32.34±3.78 | ns |
| BMI (kg/m2) | 25.62±4.03 | 26.86±3.12 | ns |
| SBP (mmHg) | 118.50±12.02 | 119.56±10.20 | ns |
| DBP (mmHg) | 68.46±8.78 | 67.32±8.52 | ns |
| FBG (mg/dl) | 85.78±7.13 | 85.20±7.35 | ns |
| HbA1c (mmol/mol) | 31.85±8.25 | 31.55±7.80 | ns |
| Hb (g/dl) | 13.10±1.52 | 12.87±1.67 | ns |
Data are presented as mean ± standard deviation. P<0.05 was considered to indicate a statistically significant difference. Ns, no significant; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; HbA1c, glycated hemoglobin; Hb, hemoglobin.